Health News Releases

  • Today April 15
Aster Guardians Global Nursing Award worth USD 250,000 (Photo: AETOSWire)
September 12, 2025 13:35
Nominations Open for Fifth Edition of Aster Guardians Global Nursing Award 2026 Worth USD 250,000
Aster DM Healthcare has announced the launch of the fifth edition of the Aster Guardians Global Nursing Award, one of the world’s most prominent recognition for nursing excellence worth USD 250,000.
September 12, 2025 10:55
Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase
Promega Corporation (https://www.promega.kr/?utm_source=businesswire.com&utm_medium=referral&utm_campaign=%28referral%29) has entered a strategic partnership with Watchmaker Genomics (https://www.watc
September 11, 2025 15:50
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking pla
September 10, 2025 16:30
Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
Galderma (SIX: GALD) today announced the launch of four core Alastin® products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare mar
September 10, 2025 16:00
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer
Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory m
September 08, 2025 17:39
Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Fstock-information%2F&esheet=54319980&newsitemid=20250908503054&lan=en-US&ancho
September 07, 2025 16:11
U.S. FDA Approves Expanded Indication for VONVENDI® [von Willebrand factor (Recombinant)] for Adults and Children with Von Willebrand Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Rec
Amazfit is proud to celebrate Ruth Croft’s achievement at the 2025 UTMB, earning first place and com
September 07, 2025 16:00
Amazfit Ambassador Ruth Croft Claims Victory at the 2025 UTMB
Amazfit (https://us.amazfit.com/), a leading global smart wearable brand by Zepp Health (NYSE: ZEPP), is proud to celebrate Ruth Croft’s achievement at the 2025 UTMB, earning first place and completin
Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core as
September 07, 2025 15:50
Zepp Health Acquires Core Assets of Wild.AI to Expand Support for Female Athletes Across Life Stages
Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimiz
RIGAKU/JEOL-iCeMS Innovation Core
September 07, 2025 12:20
Rigaku Joins Two Partners in Establishing RIGAKU/JEOL-iCeMS Innovation Core and Concluding a Cooperation Agreement
On September 4, 2025, Rigaku Corporation, a global solution partner in X-ray analytical systems and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President & CEO: Jun
Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solu
September 05, 2025 17:15
Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
Biocytogen Pharmaceuticals (https://biocytogen.com/) (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drug
September 05, 2025 14:30
From AI-powered EHRs to Real-Time Data Sharing, InterSystems Asia Healthcare Summit 2025 Spotlights Indonesia as a Digital Health Beacon in Southeast Asia
InterSystems, a creative data technology provider managing more than one billion health records globally, recently held their Asia Healthcare Summit 2025, bringing together more than 200 regional and
Credit: IFF
September 05, 2025 12:00
IFF’s Designed Enzymatic Biomaterials™ Platform Sees First Large-Scale Use in Home Care Applications
IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.iff.com&esheet=54317958&newsitemid=20250904544995&lan=en-US&anchor=IFF&index=1&md5=6f4e9fc0d09b0ce3e1b691904d2aa7c2) (NYSE: I
September 04, 2025 14:38
MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 millio
September 03, 2025 16:40
Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars
Polpharma Biologics S.A. (“Polpharma Biologics”), specialized in the development and manufacturing of biosimilars, today announced that it has signed licensing agreements with MS Pharma, a leading bio
September 03, 2025 09:53
Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
Merck, a leading science and technology company, today announced the appointment of David Weinreich, MD, MBA, as Global Head of R&D and Chief Medical Officer for its Healthcare business sector. Wei
IFF Tackles Top Challenges in Baking at IBIE 2025
September 03, 2025 09:47
IFF Tackles Top Challenges in Baking at IBIE 2025
IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.iff.com&esheet=54316321&newsitemid=20250902465856&lan=en-US&anchor=IFF&index=1&md5=e0f385d40a254be09c3e473ae8058dde) (NYSE: IF
August 31, 2025 14:35
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) o
August 29, 2025 11:30
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a signifi
(Credit: Reservas Votorantim) Images of Legado das Águas – Atlantic Forest Reserve in Brazil
August 28, 2025 11:20
IFF and Reservas Votorantim Sign Bioprospecting Partnership in Brazil
IFF (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.iff.com%2F&esheet=54313323&newsitemid=20250827881934&lan=en-US&anchor=IFF&index=1&md5=aa3a4d050325a3165d01099ca70062f3) (NYSE
SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
August 26, 2025 13:40
SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announ
August 26, 2025 10:50
BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54312218&newsitemid=20250825210828&lan=en-US&anchor=BeOne+Medicines+Ltd&index=1&md5
August 22, 2025 09:35
European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54311084&newsitemid=20250821182068&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5
August 13, 2025 10:10
PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis
Kinaxis® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54306533&newsitemid=20250812652131&lan=en-US&anchor=Kinaxis%26%23174%3B&index=1&md5=43390a81b573
August 08, 2025 17:10
Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016
Polpharma Biologics S.A. (“Polpharma Biologics”) announces a global (except for Middle East & North Africa) licensing agreement with Fresenius Kabi for the commercialization of PB016, a proposed biosi
25 per page50 per page75 per page100 per page